[1] FAUSER B C,TARLATZIS B C,REBAR R W,et al.Consensus on women's health aspects of polycystic ovary syndrome(PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J].Fertil Steril,2012,97(1): 28-38.
[2] NAIR M K,PAPPACHAN P,BALAKRISHNAN S,et al.Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls—a 2 year follow-up study[J].Indian J Pediatr,2012,79(Suppl 1): S69-S73.
[3] TEEDE H J,MISSO M L,DEEKS A A,et al.Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline[J].Med J Aust,2011,195(6): S65-S112.
[4] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1): 19-25.
[5] AZZIZ R,CARMINA E,DEWAILLY D,et al.The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report[J].Fertil Steril,2009,91(2): 456-488.
[6] VILLARROEL C,MERINO P M,LOPEZ P,et al.Polycystic ovarian morphology in adolescents with regular menstrual cycles is associated with elevated anti-Mullerian hormone[J].Hum Reprod,2011,26(10): 2861-2868.
[7] LI L,CHEN X,MO Y,et al.Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome[J].Wien Klin Wochenschr,2010,122(17-18): 519-524.
[8] PAWELCZAK M,KENIGSBERG L,MILLA S,et al.Elevated serum anti-Mullerian hormone in adolescents with polycystic ovary syndrome: relationship to ultrasound features[J].J Pediatr Endocrinol Metab,2012,25(9-10): 983-989.
[9] MARTIN K A,CHANG R J,EHRMANN D A,et al.Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline[J].J Clin Endocrinol Metab,2008,93(4): 1105-1120.
[10] FERRIMAN D,GALLWEY J D.Clinical assessment of body hair growth in women[J].J Clin Endocrinol Metab,1961,21: 1440-1447.
[11] HATCH R,ROSENFIELD R L,KIM M H,et al.Hirsutism: implications,etiology,and management[J].Am J Obstet Gynecol,1981,140(7): 815-830.
[12] HICKEY M,DOHERTY D A,ATKINSON H,et al.Clinical,ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis[J].Hum Reprod,2011,26(6): 1469-1477.
[13] 李琳,杨冬梓,陈晓莉等.青春期多囊卵巢综合征患者临床特征分析[J].中国妇产科临床杂志,2009,10(1): 27-30.
[14] GONZALEZ M E,CANTATORE-FRANCIS J,ORLOW S J.Androgenetic alopecia in the paediatric population: a retrospective review of 57 patients[J].Br J Dermatol,2010,163(2): 378-385.
[15] al KINDI M K,al ESSRY F S,al ESSRY F S,et al.Validity of serum testosterone,free androgen index,and calculated free testosterone in women with suspected hyperandrogenism[J].Oman Med J,2012,27(6): 471-474.
[16] 马从顺,林芸,张春晖,等.血清黄体生成素与卵泡刺激素比值对卵巢多囊样改变患者确诊多囊卵巢综合征的价值[J].中华妇产科杂志,2011,46(3): 177-180.
[17] 赵赟,徐晶晶,朱铭伟,等.青春期多囊卵巢综合征患者临床、内分泌代谢紊乱特征及诊断初探[J].中华医学杂志,2010,90(25): 1729-1734.
[18] FRUZZETTI F,PERINI D,LAZZARINI V,et al.Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome[J].Gynecol Endocrinol,2009,25(5): 335-343.
[19] 尹倩倩,陈晓莉,周冉等.青春期多囊卵巢综合征的ApoB/ApoA1比值对代谢综合征的预测价值[J].中山大学学报: 医学科学版,2012,33(2): 206-211.
[20] LI L,CHEN X,HE Z,et al.Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents[J].J Pediatr Adolesc Gynecol,2012,25(6): 390-395. |
